Inotuzumab (Anti-Siglec-2 / CD22)Inotuzumab (Anti-Siglec-2 / CD22)
Move your mouse over image or click to enlarge

Inotuzumab (Anti-Siglec-2 / CD22)

Inotuzumab (Anti-Siglec-2 / CD22) is a humanized IgG4, κ monoclonal antibody that targets CD22. Inotuzumab can be used for the research of acute lymphoblastic leukaemia and non-Hodgkin lymphoma. MW : 144.78 kD.
Cat# Size Price Qty Buy
A2358-1mg*25 1mg*25
£2,432.00
A2358-1mg*5 1mg*5
£794.00
A2358-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2358

Related Documents